乙酰辅酶A结构式
|
常用名 | 乙酰辅酶A | 英文名 | Acetyl-CoA |
|---|---|---|---|---|
| CAS号 | 72-89-9 | 分子量 | 809.571 | |
| 密度 | 1.9±0.1 g/cm3 | 沸点 | N/A | |
| 分子式 | C23H38N7O17P3S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
乙酰辅酶A用途乙酰辅酶A(Acetyl CoA)是一种不透膜的中枢代谢中间体,参与TCA循环和氧化磷酸化代谢。乙酰辅酶A通过向蛋白质的翻译后乙酰化反应的目标氨基酸残基提供(唯一供体)乙酰基来调节各种细胞机制。乙酰辅酶A也是脂质合成的关键前体[1][2][3][4]。 |
| 中文名 | 乙酰辅酶A |
|---|---|
| 英文名 | acetyl-CoA |
| 英文别名 | 更多 |
| 描述 | 乙酰辅酶A(Acetyl CoA)是一种不透膜的中枢代谢中间体,参与TCA循环和氧化磷酸化代谢。乙酰辅酶A通过向蛋白质的翻译后乙酰化反应的目标氨基酸残基提供(唯一供体)乙酰基来调节各种细胞机制。乙酰辅酶A也是脂质合成的关键前体[1][2][3][4]。 |
|---|---|
| 相关类别 | |
| 靶点 |
Human Endogenous Metabolite |
| 体外研究 | 乙酰辅酶A在饥饿的 U2OS公司细胞中增加细胞质蛋白乙酰化,同时减少饥饿诱导的自噬通量。(U2OS)细胞稳定表达 绿色荧光蛋白-LC3并显微注射乙酰辅酶A;在无营养条件下,用 100 nM挡板A1孵育 3小时后固定)[2]。 |
| 体内研究 | 乙酰辅酶A通过抑制适应不良的自噬来抑制压力超负荷诱导的小鼠心肌病[2][3]。被剥夺食物 (但可以随意饮水) 24小时的小鼠在几个器官 (包括心脏和肌肉) 中表现出总 乙酰辅酶A水平显着降低,对应于蛋白质乙酰化水平的降低。相同的实验条件对大脑中 乙酰辅酶A的浓度没有重大影响,实际上会增加肝脏 乙酰辅酶A和蛋白质乙酰化水平[4]。 |
| 参考文献 |
| 密度 | 1.9±0.1 g/cm3 |
|---|---|
| 分子式 | C23H38N7O17P3S |
| 分子量 | 809.571 |
| 精确质量 | 809.125793 |
| PSA | 425.34000 |
| LogP | -3.89 |
| 折射率 | 1.718 |
|
~%
乙酰辅酶A 72-89-9 |
| 文献:Journal of the American Chemical Society, , vol. 75, p. 2520 Journal of Biological Chemistry, , vol. 203, p. 869,872, 877 |
|
~%
乙酰辅酶A 72-89-9 |
| 文献:US2013/66035 A1, ; Page/Page column ; |
|
~%
乙酰辅酶A 72-89-9 |
| 文献:Biochemische Zeitschrift, , vol. 329, p. 175 Journal of Biological Chemistry, , vol. 199, p. 65,66 |
|
~%
乙酰辅酶A 72-89-9 |
| 文献:Bioscience, biotechnology, and biochemistry, , vol. 67, # 10 p. 2106 - 2114 |
|
~%
乙酰辅酶A 72-89-9 |
| 文献:Journal of the American Chemical Society, , vol. 74, p. 3205 |
|
~%
乙酰辅酶A 72-89-9 |
| 文献:Biochemistry, , vol. 51, # 13 p. 2795 - 2803 |
|
~%
乙酰辅酶A 72-89-9 |
| 文献:Organic Letters, , vol. 9, # 20 p. 3877 - 3880 |
|
~%
乙酰辅酶A 72-89-9 |
| 文献:Biochemistry, , vol. 50, # 39 p. 8407 - 8416 |
|
~%
乙酰辅酶A 72-89-9 |
| 文献:Biochemistry, , vol. 51, # 42 p. 8422 - 8434 |
| 乙酰辅酶A上游产品 9 | |
|---|---|
| 乙酰辅酶A下游产品 9 | |
| acetylocholine |
| Azetylcholin |
| ac-CoA |
| Choline acetate |
| S-{(9R)-1-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3λ,5λ-diphosphaheptadecan-17-yl} ethanethioate (non-preferred name) |
| Acetyl-CoenzymeA |
| S-ACETYL COENZYME A |
| acetyl CoA |
| Acetyl-CoA,Tri-Na |
| O-Acetylcholine |
| S-acetylcoenzyme A |
| [3H]-Acetylcholine |
| Acetyl choline ion |
| [14C]-Acetyl-Coenzyme A |
| S-{(9R)-1-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydro-2-furanyl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3λ,5λ-diphosphaheptadecan-17-yl} ethanethioate (non-preferred name) |
| Adenosine, 5'-O-[[[[(3R)-4-[[3-[[2-(acetylthio)ethyl]amino]-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]hydroxyphosphinyl]oxy]hydroxyphosphinyl]-, 3'-(dihydrogen phosphate) |
| Coenzyme A S-Acetate |
| Choline acetate (ester) |
| trilithium,[2-[[[[4-[[3-(2-acetylsulfanylethylamino)-3-oxopropyl]amino]-3-hydroxy-2,2-dimethyl-4-oxobutoxy]-oxidophosphoryl]oxy-oxidophosphoryl]oxymethyl]-5-(6-aminopurin-9-yl)-4-hydroxyoxolan-3-yl] hydrogen phosphate,trihydrate |
| Acetyl coenzyme A |
| coenzyme A, acetyl- |
| ac-S-CoA |
| S-{(9R)-1-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydro-2-furanyl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3λ,5λ-diphosphaheptadecan-17-yl} ethanethioate |
| S-{(9R)-1-[(2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydro-2-furanyl]-3,5,9-trihydroxy-8,8-dimethyl-3,5-dioxido-10,14-dioxo-2,4,6-trioxa-11,15-diaza-3λ,5λ- diphosphaheptadecan-17-yl} ethanethioate |
| [3H]-Acetyl-Coenzyme A |
| (2-Acetoxyethyl)trimethylammonium |
| Ach |
| acetyl-S-CoA |
| Acetylcholinum |
| acetylCoA |
| Acetyl-Coenzyme A |
| [14C]-Acetylcholine |
| Coenzyme A, S-acetate |
| acetylcholine |
| acetylcholine cation |